Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment

Adoptive immunotherapy, notably involving chimeric antigen receptor (CAR)-T cells, has obtained Food and Drug Administration (FDA) approval as a treatment for various hematological malignancies, demonstrating promising preclinical efficacy against cancers. However, the intricate and resource-intensi...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yun Chang, Mingyang Chang, Xiaoping Bao, Cheng Dong
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	KeAi Communications Co., Ltd. 2024-12-01
סדרה:	Bioactive Materials
נושאים:	Adoptive cellular immunotherapy Immune cell engineering Multiple-model synergistic therapy Tumor microenvironment
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2452199X24003840
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!